| Mrs Heather M Pozzo, | |
|
4 N Double Springs Rd, Farmington, AR 72730-2522 | |
| (479) 267-5960 | |
| (479) 267-5965 |
| Full Name | Mrs Heather M Pozzo |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4 N Double Springs Rd, Farmington, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093826471 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1677 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Heather M Pozzo, 1050 Tarah Knolls Cir, Centerton, AR 72719-9031 Ph: (479) 685-2792 | Mrs Heather M Pozzo, 4 N Double Springs Rd, Farmington, AR 72730-2522 Ph: (479) 267-5960 |
News Archive
Researchers believe the MS Brain Bank, a new facility based at the University of Sydney for the collection of brain tissue, could significantly advance our understanding of Multiple Sclerosis (MS).
Tendyne Holdings, Inc., a privately held clinical stage medical device company, announced today that in November 2014 the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) was successfully implanted in the first patient of the Tendyne Feasibility Study. This was the first patient enrolled in a three continent, multicenter trial, which aims to generate insight into the safety and performance of the Tendyne device in inoperable patients suffering from mitral regurgitation.
With N95 masks in short supply, a team of bioengineers and clinical experts from Brigham and Women's Hospital and the Massachusetts Institute of Technology has been developing a new, sustainable solution for health care workers to provide protection during the pandemic.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.
There is no question that autism is on the rise and the statistics speak volumes about this dramatic increase," says Michelle Rowe, Ph.D., a professor of health services at Saint Joseph's University in Philadelphia.
› Verified 5 days ago
Miss Heather Phillips, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4 N Double Springs Rd, Farmington, AR 72730 Phone: 479-267-5960 | |
Mrs. Holland Michelle Gazaway, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 115 Bonnie Ln, Farmington, AR 72730 Phone: 903-278-8848 | |
Mrs. Zoe Loretta Allgood Mcgee, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4 N Double Springs Rd, Farmington, AR 72730 Phone: 479-267-5960 Fax: 479-267-5965 | |
Sydney Bueker, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 120 Southwinds Rd Ste 120, Farmington, AR 72730 Phone: 870-932-3600 Fax: 479-316-0372 | |
Andrea Dixon Stewart, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Southwinds Rd Ste 2, Farmington, AR 72730 Phone: 479-300-6400 | |
Tabitha Radford, S.L.P. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4 N Double Springs Rd, Farmington, AR 72730 Phone: 479-267-5960 Fax: 479-267-5965 |